Navigation Links
New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
Date:12/7/2011

EAST HANOVER, N.J., Dec. 7, 2011 /PRNewswire/ -- Updated results of a Phase III study of Afinitor® (everolimus) tablets plus exemestane, a hormonal therapy, show everolimus provided additional time women with advanced breast cancer lived without their disease progressing (progression-free survival)(1).

The study findings, which represent an additional five months of follow-up, were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). Simultaneously, initial results of BOLERO-2 were published today in The New England Journal of Medicine (NEJM) and were first presented at the 2011 European Multidisciplinary Cancer Congress (EMCC)(2).

"These data provide longer-term evidence of the benefit of adding everolimus to hormonal therapy in patients whose disease progressed while on or following initial hormonal treatment, representing a major paradigm shift in the management of ER+HER2- breast cancer," said Gabriel Hortobagyi, MD, Chair of Breast Medical Oncology, University of Texas MD Anderson Cancer Center and lead study author. "Everolimus is the first treatment to enhance the efficacy of hormonal therapy in this patient population, where there remains a significant unmet need."  

Updated findings from the BOLERO-2 study presented at SABCS showed treatment with everolimus plus hormonal therapy more than doubled progression-free survival (PFS) to 7.4 months compared to 3.2 months with hormonal therapy alone (hazard ratio=0.44 [95% confidence interval (CI): 0.36 to 0.53]; p<1x10-16) by local investigator assessment. Twelve-month estimates of patients without disease progression were 31% and 10% in the everolimus and exemestane, and exemestane-alone arms, respectively. An additional analysis based on an independent central radiology review showed everolimus extended PFS to 11.0 months compared to 4.1 months (hazard ratio=0.36 [95% CI: 0.28 to 0.45]; p<1x10-16)(1).

Response rates and clinica
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Mylan Confirms First-to-File Patent Challenge Relating to Generess™ Fe
2. Watson Confirms Exelon(R) Patent Challenge
3. Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott
4. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
5. Watson Confirms Daytrana(R) Patent Challenge
6. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
7. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
8. Watson Confirms EMBEDA(R) Patent Challenge
9. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
10. Watson Confirms Amphastar Patent Lawsuit
11. Qmed - The Premier Source for OEMs Seeking Suppliers and Products in Medical Device Industry - Reconfirms its Leadership with the Highest Traffic Month to Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015  Physicians and payers alone do not ... Patients are better informed and getting increasingly involved ... This shift in power is reshaping the healthcare ... marketing. As part of this evolving ... important to educate, communicate and engage patients throughout ...
(Date:7/31/2015)... 31, 2015  In today,s ever-changing marketplace, call centers ... mobile, increasingly connected, and increasingly impatient with slow service. ... interaction channels and tools is driving call centers to ... According to research by benchmarking firm, Best ... segment in a call center study realize the impact ...
(Date:7/31/2015)... July 31, 2015  Seeger Weiss LLP is reporting that ... a warning letter to C.R. Bard, the manufacturer of ... strides to correct violations the agency found at two of ... after the FDA cited them during Inspectional Observations that occurred ... Tempe, AZ , location and on October ...
Breaking Medicine Technology:Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3
(Date:8/1/2015)... ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director ... Appalachian Trail by stepping off Springer Mountain and heading north. Since that day, ... Phil reached Connecticut and was greeted by friends and family. He visited CCAR and ...
(Date:7/31/2015)... ... 2015 , ... When the weather turned hot and warm-season turfgrasses, such as ... called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) for short. Incidentally, both names ... new type of sod, Super-Sod is giving away red Adirondack chairs with the Leisure ...
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reliable source for authentic tickets for ... Park. The festival will end on Sunday, August 2nd. , Music ... Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment from ...
(Date:7/31/2015)... Alexandria, VA (PRWEB) , ... July 31, 2015 ... ... Foundation) introduced its new store run by GoodThreads. The store can be accessed ... products and designs, many of which are customizable. The best part: whenever a ...
(Date:7/31/2015)... ... 2015 , ... There’s no better way to enjoy the summer weather than ... the next meal, making July the most appropriate to be National Hot Dog Month. ... , Make the next cookout different than the ones in the past. Celebrate National ...
Breaking Medicine News(10 mins):Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... at Buffalo School of Dental Medicine ,they say that ... an accurate early-warning system of risk of dying from ... in a population with a high incidence of diabetes. ... use of panoramic dental radiographs as a screening tool ...
... temperature by just a few degrees minimises brain damage resulting ... arrest - there's a great danger that the brain will ... run the risk of permanent brain damage. It's been suggested ... for oxygen and this may protect it after a cardiac ...
... an oral habit characterized by rhythmic activity of the jawbone ... sleep. It has been linked to headaches, joint discomfort// and ... both the person with bruxism as well as his or ... European countries, aimed to collect information on the prevalence of ...
... diet high in cholesterol and animal protein is linked to ... and esophagus that has been increasing rapidly.// The researchers also ... folic acid, vitamin C and vitamin B6 were associated with ... rate of a specific type of esophageal and stomach cancer, ...
... that causes a rare bone disease in which the body ... treatments for osteoporosis. According to Dr. Michael Levyn, director of ... finding will help bone researchers understand why the body loses ... ,Later, Levine explained the researchers studied DNA from ...
... new study shows there is some truth in the 'use ... brain active. It is long been believed that mental stimulation ... Rush Alzheimer's Disease Centre in the US now reveal new ... Religious Orders Study, involving the cognitive health of older Catholic ...
Cached Medicine News:Health News:Mutation connected to Osteoporosis 2
#2 TigerWire, a white suture with black spiral markings, was created specifically for arthroscopic surgeons that require superior suture visibility, easier arthroscopic orientation and motion determi...
TigerStick is a white #2 FiberStick with black stripes and a stiffened, 12 inch, waxed end. It is especially useful when motion determination and alternating colored sutures are required in the arthr...
... an easy one step approach to creating ... the Bio-Tenodesis Driver. Instead of using a ... retrograde through the tip of the Bio-Tenodesis ... as a suture shuttle for passage of ...
... is an ultra-high strength 2 ... long chain polyethylene structure of ... footprint of the FiberTape is ... cuff tissue where tissue pull-through ...
Medicine Products: